Virtu Financial LLC bought a new position in Global Medical REIT Inc. (NYSE:GMRE - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 28,701 shares of the company's stock, valued at approximately $222,000.
Several other institutional investors have also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new stake in shares of Global Medical REIT in the fourth quarter valued at about $1,430,000. JPMorgan Chase & Co. grew its holdings in Global Medical REIT by 54.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,927 shares of the company's stock valued at $2,298,000 after buying an additional 81,596 shares during the last quarter. Franklin Resources Inc. grew its holdings in Global Medical REIT by 228.9% in the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock valued at $1,073,000 after buying an additional 80,030 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Global Medical REIT by 158.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 120,614 shares of the company's stock worth $1,195,000 after buying an additional 73,965 shares during the period. Finally, Barclays PLC lifted its holdings in shares of Global Medical REIT by 87.1% during the third quarter. Barclays PLC now owns 154,051 shares of the company's stock worth $1,527,000 after buying an additional 71,704 shares during the last quarter. Institutional investors own 57.52% of the company's stock.
Global Medical REIT Stock Performance
Shares of Global Medical REIT stock traded down $0.12 during midday trading on Wednesday, hitting $8.60. The company had a trading volume of 482,809 shares, compared to its average volume of 425,824. Global Medical REIT Inc. has a 1-year low of $7.33 and a 1-year high of $10.46. The business's 50 day simple moving average is $8.40 and its two-hundred day simple moving average is $8.65. The stock has a market cap of $575.09 million, a PE ratio of -429.79, a P/E/G ratio of 1.43 and a beta of 1.12. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28.
Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.21. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The firm had revenue of $35.16 million during the quarter, compared to the consensus estimate of $34.87 million. As a group, equities analysts predict that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Friday, March 21st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, March 21st. This represents a $0.84 annualized dividend and a yield of 9.77%. Global Medical REIT's dividend payout ratio is 8,400.00%.
About Global Medical REIT
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Further Reading

Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.